Ilolangulu, Millennium Villages Project

 Partnership objectives

  1. Assist Ilolangulu Village in Tanzania to achieve the Millennium Development Goals (MDGs).
  2. Improve access to effective malaria treatment by donating artemisinin-based combination therapy (ACT) Coartem®, produced by Novartis, to all 80 Millennium Villages for the treatment of uncomplicated malaria.

The Novartis Foundation supports the Ilolangulu Millennium Village in Tanzania. The Novartis Foundation supports the Ilolangulu Millennium Village in Tanzania. Copyright Novartis Foundation for Sustainable Development

Description of partnership activities and how they address needs and challenges

The Millennium Villages Project (MVP) was founded with the goal of helping impoverished communities in rural Africa achieve the Millennium Development Goals (MDGs), formulated and agreed on by all member countries of the United Nations. The MVP is active at 14 sites in 10 African countries.

In 2007 the Novartis Foundation for Sustainable Development (NFSD) began support of the Millennium Villages Project (MVP) in health-related research interventions. The MVP was founded with the goal of helping impoverished communities in rural Africa achieve the MDGs. Over five years the NFSD is investing in the transition of Ilolangulu village in Tanzania from mainly subsistence farming to more self-sustaining commercial activity.

The NFSD also donated ACT Coartem for the treatment of malaria in MVP sites all over sub-Saharan Africa where Coartem is registered on the national essential drugs list.

Lessons learned

The MVP shows that fighting poverty at a village level through community-led development is an effective way of reaching the MDGs.        

Summary of impact through December 2013 and forward looking information

In 2011 the villages of the Mbola cluster are increasingly self-financing and experiencing growth in business and entrepreneurship. The cluster formation of the villages is clearly an essential part of this success, allowing all villages to benefit from lower costs, shared investments and distributed knowledge. In total 4,253 patients were reached with improved health services and products in Ilolangulu in 2010; new clinics, dispensaries and health outreach programs in many surrounding villages have reduced the burden on the village’s health facility.

Looking ahead, access to agricultural finance and the promotion of business development need to be scaled up for the benefit of all communities. Expansion of the electricity grid and the introduction of alternative energy sources such as SharedSolar panels must continue so that power sources are accessible to all. It is also vital that power is available in locations such as health centers and schools where it is most needed. Piped water systems and large scale irrigation projects need to be expanded to maintain the cleanliness of local water sources, and there is a clear need for further community awareness schemes on protecting fresh water springs and using latrines. Additionally, cluster-wide mobile telephone and internet connections need to be broadened and improved.

Partnership information

Company(ies) Novartis

Partner(s) Earth Institute at Columbia University, Millennium Promise, UNDP

Type of Partner(s) Academia / Hospitals, IGOs, NGOs

Therapeutic Focus Infectious Diseases, Other

Disease(s) General Health, Malaria

Program Type(s) Availability of Treatment - Product Donations, Health System Infrastructure - Development of Physical Infrastructure, Health System Infrastructure - Training

Targeted Population(s) General population, Marginalised / Indigenous People, People with low income

Region(s) Sub-Saharan Africa

Number of Countries 1

Country(ies) Tanzania

Start Date 2007

More information Millennium Villages Project

Completed date 2012